Financial reports
20-F/A
2021 FY
Annual report (foreign) (amended)
5 Apr 22
20-F
2021 FY
Annual report (foreign)
24 Mar 22
20-F/A
2020 FY
Annual report (foreign) (amended)
26 Mar 21
20-F/A
2020 FY
Annual report (foreign) (amended)
19 Mar 21
20-F
2020 FY
Annual report (foreign)
18 Mar 21
20-F
2019 FY
Annual report (foreign)
13 Mar 20
20-F/A
2018 FY
Annual report (foreign) (amended)
5 Sep 19
20-F
2018 FY
Annual report (foreign)
15 Mar 19
20-F
2017 FY
Annual report (foreign)
13 Mar 18
Current reports
6-K
Company announcement – No. 38 / 2022
7 Sep 22
6-K
Company announcement – No. 37 / 2022
31 Aug 22
6-K
Company Announcement – No. 36 / 2022
26 Aug 22
6-K
Current report (foreign)
10 Aug 22
6-K
Zealand Pharma launches long-term incentive program for Zealand’s Corporate Management and employees for 2022
2 Jun 22
6-K
Company announcement – No. 22 / 2022
24 May 22
6-K
Company announcement – No. 21 / 2022
20 May 22
6-K
Interim report for Q1 2022
16 May 22
6-K
Company announcement – No. 14 / 2022
22 Apr 22
6-K
Company announcement – No. 10 / 2022
30 Mar 22
Registration and prospectus
15F-12B
Securities registration termination (foreign)
30 Sep 22
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Sep 22
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Sep 22
25
Voluntary exchange delisting
20 Sep 22
S-8
Registration of securities for employees
25 May 22
S-8
Registration of securities for employees
4 Oct 21
F-3
Shelf registration (foreign)
1 Apr 19
424B4
Prospectus supplement with pricing info
9 Aug 17
F-1MEF
Registration statement to add securities to prior F-1 registration
8 Aug 17
F-1/A
Registration statement (foreign) (amended)
8 Aug 17
Proxies
No filings
Other
CT ORDER
Confidential treatment order
24 Jun 20
UPLOAD
Letter from SEC
26 Sep 19
CORRESP
Correspondence with SEC
5 Sep 19
UPLOAD
Letter from SEC
21 Aug 19
EFFECT
Notice of effectiveness
16 Apr 19
CORRESP
Correspondence with SEC
11 Apr 19
CT ORDER
Confidential treatment order
8 Apr 19
UPLOAD
Letter from SEC
8 Apr 19
CT ORDER
Confidential treatment order
9 Aug 17
EFFECT
Notice of effectiveness
8 Aug 17
Ownership
SC 13G/A
VAN HERK INVESTMENTS B.V.
14 Feb 22
SC 13G/A
WELLINGTON MANAGEMENT GROUP LLP
3 Feb 21
SC 13G/A
VAN HERK INVESTMENTS B.V.
29 Jan 21
SC 13G/A
Zealand Pharma A/S
14 Feb 20
SC 13G/A
Beneficial ownership report (amended)
28 Jan 20
SC 13G/A
Zealand Pharma A/S
18 Sep 19
SC 13G/A
Zealand Pharma A/S
17 Sep 19
SC 13G/A
Zealand Pharma A/S
14 Feb 19
SC 13G/A
Zealand Pharma A/S
12 Feb 19
SC 13G
Zealand Pharma A/S
13 Jul 18